PMA/IONO affects diffuse large B-cell lymphoma cell growth through upregulation of A20 expression.

Abstract:

:Diffuse large B-cell lymphoma (DLBCL) is a common non-Hodgkin lymphoma. A20 and mucosa-associated lymphoid tissue lymphoma translocation gene 1 (MALT1) are known to be related to DLBCL pathogenesis and progression. This study aimed to assess the effects of phorbol myristate acetate/ionomycin (PMA/IONO) on the growth and apoptosis of the DLBCL cell line OCI-LY1, and their associations with A20, MALT1 and survivin levels. Cell viability was assessed by MTT assay. Cell cycle distribution and apoptosis were evaluated using flow cytometry after incubation with Annexin V-FITC/propidium iodide (PI) and RNase/PI, respectively. Gene and protein expression levels were determined by quantitative real-time PCR and western blotting, respectively. To further determine the role of A20, this gene was silenced in the OCI-LY1 cell line by specific siRNA transfection. A20 protein levels were higher in the OCI-LY1 cells treated with PMA/IONO compared with the controls, and were positively correlated with the concentration and treatment time of IONO, but not with changes of PMA and MALT1. Meanwhile, survivin expression was reduced in the OCI-LY1 cells after PMA/IONO treatment. In addition, OCI-LY1 proliferation was markedly inhibited, with a negative correlation between cell viability and IONO concentration. In concordance, apoptosis rates were higher in the OCI-LY1 cells after PMA + IONO treatment. Cell cycle distribution differed between the OCI-LY1 cells with and without PMA/IONO treatment only at 24 h, with increased cells in the G0/G1 stage after PMA/IONO treatment. These findings indicate that PMA/IONO promotes the apoptosis and inhibits the growth of DLBCL cells, in association with A20 upregulation. Thus, A20 may be a potential therapeutic target for DLBCL.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Yang W,Li Y,Li P,Wang L

doi

10.3892/or.2016.4899

subject

Has Abstract

pub_date

2016-08-01 00:00:00

pages

1069-75

issue

2

eissn

1021-335X

issn

1791-2431

journal_volume

36

pub_type

杂志文章
  • Effects of active bufadienolide compounds on human cancer cells and CD4+CD25+Foxp3+ regulatory T cells in mitogen-activated human peripheral blood mononuclear cells.

    abstract::The growth inhibitory effects of bufadienolide compounds were investigated in two intractable cancer cells, a human glioblastoma cell line U-87 and a pancreatic cancer cell line SW1990. Among four bufadienolide compounds, a dose-dependent cytotoxicity was observed in these cancer cells after treatment with gamabufotal...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4946

    authors: Yuan B,He J,Kisoh K,Hayashi H,Tanaka S,Si N,Zhao HY,Hirano T,Bian B,Takagi N

    更新日期:2016-09-01 00:00:00

  • Identification of novel therapeutic targets in the secretome of ionizing radiation‑induced senescent tumor cells.

    abstract::Cellular senescence is a state of irreversible growth arrest that can be triggered by multiple mechanisms, including telomere shortening, the epigenetic derepression of the INK4α/ARF locus and DNA damage. Senescence has been considered a tumor‑suppressing mechanism that permanently arrests cells at risk for malignant ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4473

    authors: Hwang HJ,Jung SH,Lee HC,Han NK,Bae IH,Lee M,Han YH,Kang YS,Lee SJ,Park HJ,Ko YG,Lee JS

    更新日期:2016-02-01 00:00:00

  • BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosis.

    abstract::BTG1, which belongs to the BTG/Tob family, regulates cell cycle progression in a variety of cell types and appears to play roles in inhibiting proliferation, promoting apoptosis and stimulating cellular differentiation in multiple cell types. However, it remains unclear whether BTG1 is a breast cancer suppressor gene,...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2697

    authors: Zhu R,Zou ST,Wan JM,Li W,Li XL,Zhu W

    更新日期:2013-11-01 00:00:00

  • Identification of a novel HLA-A 02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene.

    abstract::Cancer immunotherapy is a promising new approach to cancer treatment. It has been demonstrated that a high number of tumor-specific cytotoxic T cells (CTLs) is associated with increased disease-specific survival in lung cancer patients. Identification of superior CTL epitopes from tumor antigens is essential for the d...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3198

    authors: Yoshimura M,Tada Y,Ofuzi K,Yamamoto M,Nakatsura T

    更新日期:2014-07-01 00:00:00

  • The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy (Review).

    abstract::The WHO clearly identifies tumors as a curable or a chronic disease. The use of natural agents in cancer prevention and therapy is currently playing an important role. Our laboratory has been investigating various natural phenolic compounds, including grifolin, neoalbaconol and epigallocatechin-3-gallate (EGCG). In th...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.2015.4029

    authors: Luo X,Yu X,Liu S,Deng Q,Liu X,Peng S,Li H,Liu J,Cao Y

    更新日期:2015-08-01 00:00:00

  • miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.

    abstract::microRNAs (miRNAs) are known to be involved in the pathogenesis of hepatocellular carcinoma (HCC). miR-128-3p was recently reported to be deregulated in several types of cancer. However, the biological function and potential mechanisms of miR-128-3p in HCC remain unknown. In the present study, we found that miR-128-3p...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3936

    authors: Huang CY,Huang XP,Zhu JY,Chen ZG,Li XJ,Zhang XH,Huang S,He JB,Lian F,Zhao YN,Wu GB

    更新日期:2015-06-01 00:00:00

  • Improved sensitivity and specificity for prostate cancer diagnosis based on the urine PCA3/PSA ratio acquired by sequence‑specific RNA capture.

    abstract::Prostate cancer antigen 3 (PCA3) is a non-coding RNA fragment that is overexpressed in prostate cancer cells. However, the clinical applications of PCA3 are highly limited due to the instability of RNA and the lack of reliable and efficient RNA extraction and purification methods. Thus, in the present study, we compar...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4266

    authors: Zheng K,Dou Y,He L,Li H,Zhang Z,Chen Y,Ye A,Liu W,Kong L

    更新日期:2015-11-01 00:00:00

  • microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.

    abstract::microRNAs (miRNAs), small non-coding RNAs, have emerged as key regulators of a large number of genes. The present study aimed to explore novel biological functions of miR-330 in the human prostate cancer cell lines DU145 and PC3. We confirmed that miR-330 was downregulated and inversely correlated with specificity pro...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2452

    authors: Mao Y,Chen H,Lin Y,Xu X,Hu Z,Zhu Y,Wu J,Xu X,Zheng X,Xie L

    更新日期:2013-07-01 00:00:00

  • ERK2 CD domain mutation from a human cancer cell line enhanced anchorage-independent cell growth and abnormality in Drosophila.

    abstract::In a human cancer cell line, we previously found a mutation in codon 322 of the extracellular signal-regulated kinase (ERK2E322K), the protein showed a faster migration when compared to wild-type in SDS-PAGE and constitutive phosphorylation. However, the reason for the faster migration, and the biochemical and biologi...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Mahalingam M,Arvind R,Ida H,Murugan AK,Yamaguchi M,Tsuchida N

    更新日期:2008-10-01 00:00:00

  • Loss of ONECUT1 expression in human pancreatic cancer cells.

    abstract::ONECUT1 (HNF-6) is the prototype of a new class of homeodomain transcription factors, that controls the development of pancreatic ducts during mouse development. In the present study, the role of ONECUT1 and its targeted genes TCF2, PKHD1 and CYS1 was analyzed in human pancreatic ductal adenocarcinoma (PDAC). mRNA lev...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Jiang X,Zhang W,Kayed H,Zheng P,Giese NA,Friess H,Kleeff J

    更新日期:2008-01-01 00:00:00

  • Diagnostic and therapeutic role of microRNAs in oral cancer (Review).

    abstract::Oral cancer is one of the leading types of cancer and remains the most common cause of cancer‑related mortality in Asia. The pathogenesis of oral cancer is complicated and, due to lack of accurate diagnostic methods and efficient treatment strategies, oral cancer is responsible for a large number of deaths. Therefore,...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7854

    authors: Wang J,Lv N,Lu X,Yuan R,Chen Z,Yu J

    更新日期:2021-01-01 00:00:00

  • AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.

    abstract::Osteosarcoma (OS) has an unfavorable prognosis and tends to metastasize to lung tissue. Although the CXCL12-CXCR4 axis appears to affect progression and metastasis in numerous tumors, its mechanism and downstream pathways in OS remain unclear. We used western blotting and flow cytometry to detect CXCR4 and CXCR7 expre...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3992

    authors: Liao YX,Fu ZZ,Zhou CH,Shan LC,Wang ZY,Yin F,Zheng LP,Hua YQ,Cai ZD

    更新日期:2015-07-01 00:00:00

  • Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.

    abstract::The aim of the present study was to uncover potential prognostic microRNA (miRNA) markers in head and neck squamous cell carcinoma (HNSCC). miRNA expression profile and clinical data were obtained from The Cancer Genome Atlas (TCGA) database. Survival analysis was conducted by Kaplan-Meier method. Then, candidate prog...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4698

    authors: Hui L,Wu H,Yang N,Guo X,Jang X

    更新日期:2016-06-01 00:00:00

  • The bacterial polysaccharide tecogalan blocks growth of breast cancer cells in vivo.

    abstract::The growth of supportive tissue during the progression of solid tumors is an absolute requirement for the nourishment of the tumor. The blockade of this proliferative response of normal tissues to the growing tumor should hence inhibit tumor progression. We have shown earlier, that the heparinoid pentosan polysulfate ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yunmbam MK,Wellstein A

    更新日期:2001-01-01 00:00:00

  • Perillyl alcohol causes G1 arrest through p15(INK4b) and p21(WAF1/Cip1) induction.

    abstract::The monoterpene perillyl alcohol (POH) is a naturally occurring compound derived from citrus fruits, mint and herbs. It exhibited chemotherapeutic potential against various malignant tumors in preclinical models and is currently being tested in clinical trials in patients with refractory advanced cancers. POH inhibits...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2167

    authors: Koyama M,Sowa Y,Hitomi T,Iizumi Y,Watanabe M,Taniguchi T,Ichikawa M,Sakai T

    更新日期:2013-02-01 00:00:00

  • The effect of NET-1 on the proliferation, migration and endocytosis of the SMMC-7721 HCC cell line.

    abstract::To explore the effect of NET-1 on the proliferation, migration and endocytosis in the hepatocellular carcinoma (HCC) cell line SMMC-7721, we constructed the pU6H1-NET-1-siRNA (NET-1siRNA) and pcDNA3.1/myc-NET-1 (myc-NET-1) vectors and transfected them into SMMC-7721 cells. The expression levels of NET-1 mRNA and prote...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1698

    authors: Wang GL,Chen L,Wei YZ,Zhou JM,Wu YY,Zhang YX,Qin J,Zhu YY

    更新日期:2012-06-01 00:00:00

  • Mutational analysis of Smad7 in human cervical cancer.

    abstract::Our aim was to carry out mutational analysis of Smad7 exon 4 that codes for the Smad7 MH2 domain in human cervical cancer tissues. This study is warranted since genetic abnormalities of components of the transforming growth factor-beta (TGF-beta)/Smad signaling system have been implicated in a variety of human cancers...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000315

    authors: Hariharan R,Babu JM,P R,Pillai MR

    更新日期:2009-04-01 00:00:00

  • Induction of DNA damage by deguelin is mediated through reducing DNA repair genes in human non-small cell lung cancer NCI-H460 cells.

    abstract::It has been shown that deguelin, one of the compounds of rotenoids from flavonoid family, induced cytotoxic effects through induction of cell cycle arrest and apoptosis in many types of human cancer cell lines, but deguelin-affected DNA damage and repair gene expression (mRNA) are not clarified yet. We investigated th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1622

    authors: Ji BC,Yu CC,Yang ST,Hsia TC,Yang JS,Lai KC,Ko YC,Lin JJ,Lai TY,Chung JG

    更新日期:2012-04-01 00:00:00

  • Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.

    abstract::Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death. Tumor specific cellular and humoral immunotherapy may be a viable approach for the treatment of HCC. This study investigated specific inhibitory and cytotoxic effects on hepatocellular carcinoma (HCC) induced by the peptide, designated HBc Delt...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kong J,Diao Z,Deng X,Zhong H,Yao W,Hu X

    更新日期:2007-07-01 00:00:00

  • Simvastatin and lovastatin inhibit breast cell invasion induced by H-Ras.

    abstract::Breast cancer mortality is strongly related to the invasive and metastatic potential of tumor cells. We previously showed that an active mutant of H-Ras induced invasive phenotype of MCF10A human breast epithelial cells. Membrane anchoring of Ras requires isoprenylation which involves the activity of 3-hydroxy 3-methy...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000357

    authors: Kang S,Kim ES,Moon A

    更新日期:2009-05-01 00:00:00

  • Combination effects of irradiation and irinotecan on cervical squamous cell carcinoma cells in vitro.

    abstract::Irinotecan HCl (CPT-11) has frequently been used in chemotherapy or concurrent chemoradiotherapy for patients with advanced cervical cancer, although an effective protocol for chemoradiotherapy with CPT-11 has not yet been established. Using the radiosensitive human cervical squamous cell carcinoma cell line ME180 and...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Tanaka T,Yukawa K,Umesaki N

    更新日期:2005-11-01 00:00:00

  • Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results.

    abstract::In the present study, the preliminary results of the first stereotactic body radiosurgery (SRS) experience with volumetric intensity modulated arc therapy (VMAT) in oligometastatic breast and recurrent gynecological tumors (OBRGT) are reported in terms of feasibility, toxicity and efficacy. Patients were treated in a ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3412

    authors: Macchia G,Deodato F,Cilla S,Torre G,Corrado G,Legge F,Gambacorta MA,Tagliaferri L,Mignogna S,Scambia G,Valentini V,Morganti AG,Ferrandina G

    更新日期:2014-11-01 00:00:00

  • Expression of DNA double-strand break repair proteins predicts the response and prognosis of colorectal cancer patients undergoing oxaliplatin-based chemotherapy.

    abstract::DNA intrastrand cross-linking agents such as oxaliplatin induce DNA double-strand breaks (DSBs) during DNA repair and replication. In the present study, we hypothesized that DNA intrastrand cross-linking agents may significantly benefit colorectal cancer patients with deficiencies in DSB repair. Seventy-eight patients...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4488

    authors: Ihara K,Yamaguchi S,Ueno N,Tani Y,Shida Y,Ogata H,Domeki Y,Okamoto K,Nakajima M,Sasaki K,Tsuchioka T,Mitomi H,Kato H

    更新日期:2016-03-01 00:00:00

  • Epigenetic DNA-methylation regulation of genes coding for lipid raft-associated components: a role for raft proteins in cell transformation and cancer progression (review).

    abstract::Metastatic progression is the cause of most cancer deaths. Host tumour cell separation (fission) is accompanied by simultaneous acquisition of migrating capability of cancer cells, remodeling of cellular architecture and effective 'homing' in body host environment. Cell remodeling involves cytoskeletal protein-protein...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:

    authors: Patra SK,Bettuzzi S

    更新日期:2007-06-01 00:00:00

  • Tissue factor regulates tumor angiogenesis of retinoblastoma via the extracellular signal-regulated kinase pathway.

    abstract::Retinoblastoma, a well-vascularized tumor that is dependent on a very robust angiogenic response, is the most common intraocular malignancy in children. Tissue factor (TF) is known to regulate tumor progression and in the present study we demonstrated that TF regulates tumor angioge...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2048

    authors: Song HB,Park KD,Kim JH,Kim DH,Yu YS,Kim JH

    更新日期:2012-12-01 00:00:00

  • Pathotropic targeting advances clinical oncology: tumor-targeted localization of therapeutic gene delivery.

    abstract::The advent of pathotropic (disease-seeking) targeting has transported genetic medicine across the threshold of history with the progressive clinical validation of Rexin-G, a tumor-targeted nanosized anti-cancer agent. Achieving noteworthy single-agent efficacy and survival benefits in otherwise intractable cancers, th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.829

    authors: Hall FL,Levy JP,Reed RA,Petchpud WN,Chua VS,Chawla SP,Gordon EM

    更新日期:2010-10-01 00:00:00

  • TIPE2 inhibits GC via regulation of cell proliferation, apoptosis and inflammation.

    abstract::Gastric cancer (GC), a type of gastric mucosal epithelium disease caused by common malignant tumors, has become a major threat to human health and survival. Tumor necrosis factor‑α‑induced protein‑8 like‑2 (TIPE2) is a negative immune regulatory factor that is selectively expressed in immune organs, immune cells and v...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6576

    authors: Lin Z,Liu W,Xiao C,Fan Y,Zhuang G,Qi Z

    更新日期:2018-09-01 00:00:00

  • MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28.

    abstract::As a common malignancy of the endocrine system, papillary thyroid carcinoma (PTC) seriously affects the quality of life of patients. lncRNA PAX8‑AS1:28, or lnc‑PSD4‑1:14 has been reported to be abnormally expressed in PTC. However, the function of PAX8‑AS1:28 in PTC is still unknown. Therefore, the present study aimed...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.6996

    authors: Zhang Y,Li F,Chen J

    更新日期:2019-04-01 00:00:00

  • Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.

    abstract::The ING1 gene is involved in the regulation of the cell cycle, senescence, and apoptosis and is a novel candidate tumor suppressor gene. ING2, another gene in the ING family, was identified and cloned. The functions of ING1 and ING2 largely depend on the activity of p53. To determine whether an alteration in these gen...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Okano T,Gemma A,Hosoya Y,Hosomi Y,Nara M,Kokubo Y,Yoshimura A,Shibuya M,Nagashima M,Harris CC,Kudoh S

    更新日期:2006-03-01 00:00:00

  • Anti-hepatoma activities of ethyl acetate extract from Ampelopsis sinica root.

    abstract::Ampelopsis sinica root (ASR) is a known hepatoprotective folk traditional Chinese medicine. The anti‑hepatoma activity of ethyl acetate extract from A. sinica root (ASRE) in vitro and in vivo and its possible mechanism were explored. This study was designed to investigate cytotoxicity by MTT assay, induction of apopto...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5504

    authors: Wang JZ,Huang BS,Cao Y,Chen KL,Li J

    更新日期:2017-04-01 00:00:00